Clinical Trials

Connect trial imaging.Keep visits linked.

Bring baseline and follow-up scans from participating sites into one research workflow. Nexus helps prepare and route DICOM studies for review while preserving the participant and visit context your trial needs.

Participant identity and safety

Why use pseudonymisation?

When a trial needs to link scans over time and retain an authorised route back to the participant, use a stable study code and keep the code-to-identity mapping separate from the research images. Restrict access to the mapping and record when it is used. For an organisation that can identify participants using the mapping, those records remain personal data under UK GDPR.

ICO guidance on pseudonymisation
01

Follow change across visits

Use the same study code across baseline and follow-up scans. In an oncology trial using RECIST 1.1, this lets readers match the right CT studies and compare lesion measurements over time. Preserve visit order and any intervals required by the protocol.

RECIST 1.1 guidance

02

Escalate incidental findings

If a reviewer spots a potentially serious unexpected finding, the study’s escalation procedure should say whom to contact and how quickly. An authorised site team can use the study code to identify the participant and arrange clinical follow-up while preserving treatment blinding where appropriate.

HRA guidance on findings

03

Support safety follow-up

A study code lets the site and sponsor reconcile relevant images with a participant’s safety record. The investigator and sponsor assess, follow up and report safety events under the protocol and applicable rules.

MHRA guidance on safety reporting

The imaging workflow

From acquisition to review.

Nexus connects site systems to the trial’s imaging destinations. Agree what to collect, what to transform and what to verify before images reach readers.

FDA guidance on imaging endpoints
DICOM confidentiality options
01

Collect from participating sites

Agree the transfer route from each site’s PACS or imaging centre. Use the imaging charter to define the expected modality, acquisition settings, series and visit windows, and test submissions with representative studies before enrolment.

02

Prepare research copies

Replace direct identifiers with the agreed participant code. Check DICOM headers, private tags and free text for identifying details. Check image pixels separately for burned-in labels and assess whether anatomy could identify a participant. Preserve the dates or intervals, image references and acquisition details the study needs.

03

Check completeness before review

Reconcile each submission against the expected participant, visit and series. Flag missing scans, duplicate transfers, mismatches and acquisition deviations. Agree who contacts the site, how corrections are tracked and when a study is ready for review.

04

Route to the right reviewers

Deliver prepared images to the agreed imaging core lab, archive or analysis platform. Define access by role and keep treatment allocation or other restricted information out of the reader’s view where the protocol calls for blinded review. Agree what to log for receipt, changes and delivery, and how to retain and export records at closeout.

Fit the systems to the study

Connect the tools your trial uses.

Nexus can retrieve, transform and route studies to your chosen trial systems. Nexus PACS can provide a cloud imaging layer where needed. Agree who holds the identity mapping and which systems support image review, endpoint measurement and safety reporting before the trial starts.

Start with your study

Let’s map your trial imaging.

Bring your protocol or imaging charter, expected sites and modalities, and the systems that will receive the images.

Discuss clinical trial imaging